These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732 [No Abstract] [Full Text] [Related]
4. [Biochemistry of schizophrenia and mechanism of action of neuroleptics]. Loo H; Cuche H; Sechter D Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604 [TBL] [Abstract][Full Text] [Related]
5. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
6. Neuropsychopharmacology of monoamines and their regulatory enzymes. Lipton MA Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941 [No Abstract] [Full Text] [Related]
7. Studies of the autistic syndromes. Coleman M Res Publ Assoc Res Nerv Ment Dis; 1979; 57():265-75. PubMed ID: 419334 [No Abstract] [Full Text] [Related]
8. [Effect of amitriptyline on the activity of enzymes participating in biogenic amine metabolism in patients with affective disorders]. Matsumoto H; Pietruszewska I; Marcjan K Psychiatr Pol; 1983; 17(5-6):417-20. PubMed ID: 6669662 [No Abstract] [Full Text] [Related]
10. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
11. [Biogenic amines in the pathogenesis of different forms of viral infections]. Popenenkova ZA; Maslennikov GA Vestn Akad Med Nauk SSSR; 1977; (7):83-92. PubMed ID: 197741 [No Abstract] [Full Text] [Related]
12. Platelet monoamine oxidase in children with infantile autism. Boullin DJ; Bhagavan HN; Coleman M; O'Brien RA; Youdim MB Med Biol; 1975 Aug; 53(4):210-3. PubMed ID: 1186319 [TBL] [Abstract][Full Text] [Related]
13. Biochemical aspects of experimentally induced parkinsonism. Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657 [No Abstract] [Full Text] [Related]
15. Monoamines in autism: an update of neurochemical research on a pervasive developmental disorder. Anderson GM Med Biol; 1987; 65(2-3):67-74. PubMed ID: 3309489 [TBL] [Abstract][Full Text] [Related]
16. [Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)]. Lelord G; Callaway E; Muh JP; Arlot JC; Sauvage D; Garreau B; Domenech J Rev Neurol (Paris); 1978 Dec; 134(12):797-801. PubMed ID: 754238 [TBL] [Abstract][Full Text] [Related]
17. Biochemical studies of children with the syndromes of autism, childhood schizophrenia and related developmental disabilities: a review. Ritvo ER J Child Psychol Psychiatry; 1977 Sep; 18(4):373-9. PubMed ID: 914908 [No Abstract] [Full Text] [Related]
18. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface. Hardebo JE; Owman C Ann Neurol; 1980 Jul; 8(1):1-31. PubMed ID: 6105837 [TBL] [Abstract][Full Text] [Related]